Programmable cellular synthesis.
We engineer proprietary marine microalgae strains within closed-loop photobioreactors, synthesizing high-purity bioactive compounds for clinical therapeutics.






Clinical-grade cellular engineering.
Targeted molecular profiles
We isolate and program specific microalgae strains, editing metabolic pathways to synthesize targeted bioactive compounds under sterile conditions.
Photosynthetic efficiency
Our automated systems control light wavelengths and carbon inputs, maximizing thermodynamic efficiency and bioactive yield.
Molecular purity validation
Using advanced mass spectrometry and metabolic mapping, we verify compound purity and guarantee batch-to-batch consistency.


Closed-loop synthesis.
Our proprietary four-stage process translates raw carbon dioxide and light into high-value pharmaceutical precursors. By bypassing traditional agricultural constraints, we deliver molecular purity with an entirely carbon-negative thermodynamic yield.
Access technical data.
Connect with our scientific team to review our complete metabolic mapping datasets, strain library specifications, and partnership licensing frameworks.
Valgogenix Biotech
Precision microalgae synthesis for pharmaceutical compounds and enterprise carbon capture.
Platform
Overview
About
Science
Pipeline
Sustainability
Careers
Inquiries
investors@valgogenix.com
Zurich, Switzerland
Clinical Facility: Basel
© 2026 Valgogenix Biotech-Clinical-grade synthesis platforms.
MOLECULAR PURITY - CARBON-NEGATIVE YIELD
